Literature DB >> 7496328

Cancer mortality in Europe, 1990-92.

F Levi1, C La Vecchia, F Lucchini, E Negri.   

Abstract

Histograms of all age-standardized (world population) death certification rates for 23 cancers or groups of cancers for the period 1990-92 were produced for 35 countries of the European region (including a dozen new national entities) providing data to the World ealth Organization database. Substantial variations were observed in mortality from most common sites. For lung cancer the rate in males was 81/100,000 in Hungary, followed by Belgium, the Czech Republic, the Russian Federation and Poland, while in Sweden, Iceland and Norway, where comprehensive antismoking campaigns have been adopted over the last two decades, the rates were between 24 and 30 per 100,000 males. The lung cancer epidemic in European females is still in its early phases in most countries, with the sole exception of Scotland (29/100,000, ie the highest rates in the world), the rest of the UK, Denmark, Iceland, Ireland and Hungary. With reference to colorectal cancer, the highest rates were in the Czech Republic (38/100,000 males, 21/100,000 females) and other central European countries, and the lowest in Greece, Romania and a few Republics of the former Soviet Union, as well as Finland and Sweden. The highest gastric cancer mortality rates were in the Russian Federation (41/100,000 males, 18/100,000 females), followed by a few Republics of the former Soviet Union and Portugal in Western Europe. The highest breast cancer rates (25-29 per 100,000 females) were in the UK, Belgium, Ireland, The Netherlands, Denmark and other Scandinavian countries. For overall cancer mortality, the range of variation was between 260/100,000 in Hungary and 132/100,000 in Sweden for males, and between 142/100,000 in Denmark and 76/100,000 in Kyrgizstan for females, ie approximately a twofold variation in both sexes.

Entities:  

Mesh:

Year:  1995        PMID: 7496328     DOI: 10.1097/00008469-199510000-00009

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  8 in total

1.  The price of autonomy.

Authors:  Michael Baum; Jayant S. Vaidya
Journal:  Health Expect       Date:  1999-05       Impact factor: 3.377

2.  Web-based system for training and dissemination of a magnification chromoendoscopy classification.

Authors:  Mario Dinis-Ribeiro; Ricardo Correia; Cristina Santos; Sonia Fernandes; Ernesto Palhares; Rui-Almeida Silva; Pedro Amaro; Miguel Areia; Altamiro Costa-Pereira; Luis Moreira-Dias
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

Review 3.  Lung cancer. 1: prevention of lung cancer.

Authors:  G E Goodman
Journal:  Thorax       Date:  2002-11       Impact factor: 9.139

4.  Cost effectiveness of letrozole in the treatment of advanced breast cancer in postmenopausal women in the UK.

Authors:  M Nuijten; L Meester; F Waibel; S Wait
Journal:  Pharmacoeconomics       Date:  1999-10       Impact factor: 4.981

5.  Gastric cancer in a Caucasian population: role of pepsinogen C genetic variants.

Authors:  Ana L Pinto-Correia; Hugo Sousa; Maria Fragoso; Luís Moreira-Dias; Carlos Lopes; Rui Medeiros; Mário Dinis-Ribeiro
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

6.  An adsorptive transfer technique coupled with brdicka reaction to reveal the importance of metallothionein in chemotherapy with platinum based cytostatics.

Authors:  Sona Krizkova; Ivo Fabrik; Dalibor Huska; Vojtech Adam; Petr Babula; Jan Hrabeta; Tomas Eckschlager; Pavel Pochop; Denisa Darsova; Jiri Kukacka; Richard Prusa; Libuse Trnkova; Rene Kizek
Journal:  Int J Mol Sci       Date:  2010-11-26       Impact factor: 5.923

Review 7.  Asbestos and cancer: An overview of current trends in Europe.

Authors:  M Albin; C Magnani; S Krstev; E Rapiti; I Shefer
Journal:  Environ Health Perspect       Date:  1999-05       Impact factor: 9.031

Review 8.  Epidemiological trends in digestive cancers in Romania, 1955-2012, compared to alcohol consumption. Correlation or coincidence?

Authors:  Simona Valean; Romeo Chira; Dan Dumitrascu
Journal:  Clujul Med       Date:  2018-10-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.